Patents by Inventor Hernan Valdez

Hernan Valdez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Treating Coronavirus Disease 2019
    Publication number: 20230149407
    Abstract: The present invention is related to the discovery of new methods for treating the pathologic inflammatory response associated with patients infected with SARS-CoV-2 comprising administering orally to the patient in need of such treatment a therapeutically effective amount of a JAK inhibitor, a JAK/TYK inhibitor, or an IRAK4 inhibitor, or a combination thereof.
    Type: Application
    Filed: April 1, 2021
    Publication date: May 18, 2023
    Applicant: Pfizer Inc.
    Inventors: Michael Corbo, Spencer Ian Danto, Tamas Andras Koncz, Elena Peeva, Hernan Valdez, V, Michael Steven Vincent, Cara Margaret May Williams
  • Combination Therapy Comprising A CCR5 Antagonist, A HIV-1 Protease Inhibtior and a Pharmacokinetic Enhancer
    Publication number: 20130023496
    Abstract: The present invention discloses a novel combination therapy for HIV-1 treatment relying on a combination of at least one CCR5 antagonist, at least one HIV-1 protease inhibitor and at least one pharmacokinetic enhancer of said at least one CCR5 antagonist and/or at least one HIV-1 protease inhibitor. The combination is intended for use in oral treatment of a disorder selected from the group consisting of HIV-1 infection, retroviral infections genetically related to HIV and AIDS, in a treatment-naïve patient infected with CCR5 tropic HIV-1 virus.
    Type: Application
    Filed: March 30, 2011
    Publication date: January 24, 2013
    Inventors: Randy Tressler, Hernan Valdez
  • Pharmaceutical Composition of Antiviral Agents
    Publication number: 20080139495
    Abstract: In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising a compound of the formula (I) and at least one antiviral active compound of the formula (II) wherein Base is selected from the group consisting of thymine, cytosine, adenine, guanine, inosine, uracil, 5-ethyluracil and 2,6-diaminopurine.
    Type: Application
    Filed: January 25, 2008
    Publication date: June 12, 2008
    Inventors: Heinz-Gerd Klaes, Elena Koundourakis, Hernan Valdez, Douglas Lytle Mayers
  • Pharmaceutical composition of antiviral agents
    Patent number: 7244716
    Abstract: In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising tipranavir and at least one antiviral active compound of formula (I) wherein Base is selected from the group consisting of thymine, cytosine, adenine, guanine, inosine, uracil, 5-ethyluracil and 2,6-diaminopurine, or a pharmaceutically acceptable salt or prodrug thereof.
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: July 17, 2007
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Heinz-Gerd Klaes, Elena Koundourakis, Hernan Valdez, Douglas Lytle Mayers
  • Pharmaceutical composition of antiviral agents
    Publication number: 20040235781
    Abstract: In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising a compound of the formula (I) 1
    Type: Application
    Filed: March 25, 2004
    Publication date: November 25, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Heinz-Gerd Klaes, Elena Koundourakis, Hernan Valdez, Douglas Lytle Mayers
  • Pharmaceutical composition of antiviral agents
    Publication number: 20040235779
    Abstract: In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising tipranavir and at least one antiviral active compound of formula (I) 1
    Type: Application
    Filed: March 25, 2004
    Publication date: November 25, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Heinz-Gerd Klaes, Elena Koundourakis, Hernan Valdez, Douglas Lytle Mayers
  • Pharmaceutical composition of antiviral agents
    Publication number: 20040235780
    Abstract: In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising nevirapine and at least one antiviral active compound of formula (I) 1
    Type: Application
    Filed: March 25, 2004
    Publication date: November 25, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Heinz-Gerd Klaes, Elena Koundourakis, Hernan Valdez, Douglas Lytle Mayers